Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228670 · ClinicalTrials.gov registry record
Herpesvirus in Idiopathic Pulmonary Fibrosis
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 41
- Enrollment target
NCT00228670 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 41 participants.
The verdict
NCT00228670 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1) to develop a method to quantify Epstein Barr Virus (EBV) load in lung tissue of humans and to determine whether EBV viral load is significantly higher in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) than in control lung tissue; 2) to determine whether EBV localized to epithelial cells in IPF lungs and to relate epithelial positivity to tissue viral load; 3) to measure viral load in induced sputum from IPF subjects over time in order to determine whether periodic active herpes virus replication occurred in the respiratory tract; and 4) to compare longitudinal measures of viral load in induced sputum with simultaneously collected saliva in order to assess the clinical utility of the two approaches.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2005-07 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00228670
The ClinicalTrials.gov registry entry for NCT00228670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00228670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00228670 about?
NCT00228670 is a clinical study titled "Herpesvirus in Idiopathic Pulmonary Fibrosis". The purpose of this study is to: 1) to develop a method to quantify Epstein Barr Virus (EBV) load in lung tissue of humans and to determine whether EBV viral load is significantly higher in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) than in control lung tissue; 2) to determin...
What is the current status of trial NCT00228670?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2005-07. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT00228670?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.